{"id":"W4402356242","doi":"10.1097/coc.0000000000001143","title":"Efficacy and Safety of Abemaciclib in Combination With Endocrine Therapy for HR+/HER2− Advanced or Metastatic Breast Cancer","year":2024,"lang":"en","type":"review","venue":"American Journal of Clinical Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Fulvestrant; Internal medicine; Oncology; Hazard ratio; Metastatic breast cancer; Breast cancer; Adverse effect; Combination therapy; Cancer; Confidence interval; Tamoxifen","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001280063,0.0004321986,0.007010828,0.0003816935,0.00002152784,0.000006823525,0.0002156678,0.000126807,0.00006713907],"category_scores_gemma":[0.0004616702,0.000233644,0.0005780743,0.0006964451,0.00101008,0.0001078775,0.00003943107,0.001124482,0.000001175006],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003405,"about_ca_system_score_gemma":0.003357533,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002808191,"about_ca_topic_score_gemma":0.00004861225,"domain_scores_codex":[0.9950591,0.0005764754,0.003298308,0.0004133325,0.0003182183,0.0003345193],"domain_scores_gemma":[0.9899916,0.004933916,0.004104994,0.000249492,0.0004644987,0.0002554773],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.03825924,0.001055506,0.0001467251,0.002956517,0.002044,0.0002433802,0.00008218562,0.000008344392,0.000001538686,0.00004859827,0.00003106759,0.9551229],"study_design_scores_gemma":[0.02705645,0.03732241,0.001831246,0.01819541,0.003836513,0.004141785,0.0001981185,0.000007792783,0.00000136574,0.0001010169,0.9070314,0.0002764406],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002787821,0.9916074,0.0004849808,0.002453038,0.000596529,0.001897006,0.000125676,0.00001400755,0.00003355584],"genre_scores_gemma":[0.001771779,0.9847918,0.01222297,0.0004093898,0.0004468513,0.000140948,0.00001305414,0.0000972501,0.000105911],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9548464,"threshold_uncertainty_score":0.9527725,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1099644072603908,"score_gpt":0.5343017928638563,"score_spread":0.4243373856034655,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}